Activin A and bone metastasis
β Scribed by Gaetano Leto
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 163 KB
- Volume
- 225
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Activin A, is a multifunctional cytokine of the transforming growth factorβΞ² superfamily of growth factors. This molecule has been shown to be implicated in the regulation of a broad range of important biological functions including bone remodelling. Therefore, a deregulation in the activin signalling pathway may result in disturbances of normal bone metabolism and, eventually, in the onset of severe pathological conditions associated with an altered bone resorption. These observations support the concept that Act A might also be implicated in the pathogenesis of bone metastasis. This review provides insight into the most recent advances in understanding the role of this growth factor in the pathogenesis of bone metastasis, and discusses the implications related to the biomedical applications of these findings. J. Cell. Physiol. 225: 302β309, 2010. Β© 2010 WileyβLiss, Inc.
π SIMILAR VOLUMES
provides a favorable soil. In the case of breast carcinoma, the final step in bone metastasis (namely bone destruction) is mediated by osteoclasts that are stimulated by local production of the tumor peptide parathyroid hormone-related peptide (PTH-rP), whereas prostate carcinomas stimulate osteobla
The autopsy of hepatocellular carcinoma at Hines VA Hospital was reviewed for a 33-year period, between 1954 and 1986. The neoplasm is uncommon and bone involvement was observed in 7.3% or in ten of 137 cases. A clinical presentation of O S S ~O U S metastasis in hepatocellular carcinoma is rare. A